An Advanced Biomanufacturing Technology to Scale Production of Autologous iPSC-Based Cell Therapies
Time: 11:45 am
day: Day Two Track B AM
Details:
- Closed cassette-based GMP system in early development
- Automated cell culture, imaging, liquid handling, and cell removal: driven by AI-based in-process characterization and decision making
- 60 unique and clonal iPSC lines generated from a diversity of donors, with demonstrated successful differentiation in the hands of collaborators
